Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Maternal Immunization During the Second Trimester with BNT162b2 mRNA Vaccine Induces a Robust IgA Response in Human Milk: A Prospective Cohort Study.
Kigel A, Vanetik S, Mangel L, Friedman G, Nozik C, Terracina C, Taussig D, Dror Y, Samra H, Mandel D, Lubetzky R, Wine Y. Kigel A, et al. Among authors: taussig d. Am J Clin Nutr. 2023 Sep;118(3):572-578. doi: 10.1016/j.ajcnut.2023.07.013. Epub 2023 Jul 20. Am J Clin Nutr. 2023. PMID: 37479184 Free article.
When a virus lies in wait.
Taussig D, Wine Y. Taussig D, et al. Elife. 2021 Aug 4;10:e71121. doi: 10.7554/eLife.71121. Elife. 2021. PMID: 34347587 Free PMC article.
Longitudinal kinetics of RBD+ antibodies in COVID-19 recovered patients over 14 months.
Eyran T, Vaisman-Mentesh A, Taussig D, Dror Y, Aizik L, Kigel A, Rosenstein S, Bahar Y, Ini D, Tur-Kaspa R, Kournos T, Marcoviciu D, Dicker D, Wine Y. Eyran T, et al. Among authors: taussig d. PLoS Pathog. 2022 Jun 3;18(6):e1010569. doi: 10.1371/journal.ppat.1010569. eCollection 2022 Jun. PLoS Pathog. 2022. PMID: 35658051 Free PMC article.
Erratum to "Maternal Immunization During the Second Trimester with BNT162b2 mRNA Vaccine Induces a Robust IgA Response in Human Milk: A Prospective Cohort Study" [The American Journal of Clinical Nutrition volume 118 (2023) 572-578/Article Number].
Kigel A, Vanetik S, Mangel L, Friedman G, Nozik C, Terracina C, Taussig D, Dror Y, Samra H, Mandel D, Lubetzky R, Wine Y. Kigel A, et al. Among authors: taussig d. Am J Clin Nutr. 2023 Nov;118(5):1068. doi: 10.1016/j.ajcnut.2023.09.002. Epub 2023 Sep 15. Am J Clin Nutr. 2023. PMID: 37717944 Free article. No abstract available.
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy.
Othman J, Hwang A, Brodermann M, Abdallah I, McCloskey K, Gallipoli P, Clarke G, Dang R, Vidler J, Krishnamurthy P, Basheer F, Latif AL, Palanicawandar R, Taylor T, Khan A, Campbell V, Hogan F, Kanellopoulos A, Fleming K, Collins A, Dalley C, Loke J, Marshall S, Taussig D, Munisamy S, Loizou E, Yassin H, Dennis M, Zhao R, Belsham E, Murray D, Fowler N, O'Nions J, Khan A, Sellar R, Dillon R. Othman J, et al. Among authors: taussig d. Blood Adv. 2024 Nov 12;8(21):5590-5597. doi: 10.1182/bloodadvances.2024014017. Blood Adv. 2024. PMID: 39265176 Free PMC article.
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study.
Bhatla T, Hogan LE, Teachey DT, Bautista F, Moppett J, Velasco Puyó P, Micalizzi C, Rossig C, Shukla N, Gilad G, Locatelli F, Baruchel A, Zwaan CM, Bezler NS, Rubio-San-Simón A, Taussig DC, Raetz EA, Mao ZJ, Wood BL, Alvarez Arias D, Krevvata M, Nnane I, Bandyopadhyay N, Lopez Solano L, Dennis RM, Carson R, Vora A. Bhatla T, et al. Among authors: taussig dc. Blood. 2024 Nov 21;144(21):2237-2247. doi: 10.1182/blood.2024024493. Blood. 2024. PMID: 39158071 Clinical Trial.
143 results